| 1 |
[GO] |
Journal of Commercial Biotechnology |
2022―Oct―14 |
Robotics and artificial intelligence in healthcare during COVID-19 pandemic |
Lili Wang |
| 2 |
[GO] |
Journal of Commercial Biotechnology |
2022―Aug―20 |
An effective blended online Political teaching and learning strategy during the COVID-19 pandemic |
Wang Meng |
| 3 |
[GO] |
Journal of Commercial Biotechnology |
2022―Aug―11 |
Application of virtual reality technology in multimedia resource with a focus on the COVID-19 outbreak |
Na Li |
| 4 |
[GO] |
Journal of Commercial Biotechnology |
2021―Sep―10 |
Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent |
Peter J Pitts, Robert Popovian, Wayne Weingarden |
| 5 |
[GO] |
Journal of Commercial Biotechnology |
2021―Mar―18 |
The Impact of the COVID-19 Pandemic on the Content and Logistics of this Special Edition on Building and Leveraging Ecosystems and Clusters |
Arthur Boni, Moira Gunn |
| 6 |
[GO] |
Journal of Commercial Biotechnology |
2020―Oct―29 |
Could COVID-19 Cause ‘Biopharming’ to Bloom? |
Kathleen Hefferon, Henry Miller, Henry Miller |
| 7 |
[GO] |
Journal of Commercial Biotechnology |
2020―Oct―29 |
COVID-19 Diagnostic Testing: Lessons Learned for Innovative Product Development During A Public Health Emergency |
Christopher Lamb |
